Senior insider sale
President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$31.05M
934.03K shares
What this filing means
FRANCIS RICHARD D plans to sell 934.03K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $31.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001973379-26-000088
Officer· President and CEO
Since Mar 2026
934.03K
Shares to sell
$31.05M
Approx. market value
42.45K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
3/5/2025
42.45KTotal acquired42.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2025 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 42.45K | — |
| Total | 42.45K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
23.39K
Market value
$759.4K
3/4/2026
—Completed
Units to sell
442.94K
Market value
$14.33M
3/3/2026
—Completed
Units to sell
447.68K
Market value
$15.32M
2/17/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
20.02K
Market value
$634.2K
3/5/2026
Total
Units
934.03K
Value
$31.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 23.39K | $759.4K | — | Completed |
3/3/2026 | 442.94K | $14.33M | — | Completed |
2/17/2026 | 447.68K | $15.32M | — | Completed |
| Planned — Approximate Date | ||||
3/5/2026 | 20.02K | $634.2K | NYSE | Planned |
| Total | 934.03K | $31.05M | ||